Organo Statistics
Total Valuation
Organo has a market cap or net worth of JPY 667.21 billion. The enterprise value is 676.87 billion.
| Market Cap | 667.21B |
| Enterprise Value | 676.87B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Organo has 45.98 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 45.98M |
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 22.05% |
| Float | 24.62M |
Valuation Ratios
The trailing PE ratio is 23.67 and the forward PE ratio is 21.87.
| PE Ratio | 23.67 |
| Forward PE | 21.87 |
| PS Ratio | 3.81 |
| PB Ratio | 5.10 |
| P/TBV Ratio | 5.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 24.02 |
| EV / Sales | 3.86 |
| EV / EBITDA | 17.14 |
| EV / EBIT | 17.99 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.24.
| Current Ratio | 2.74 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | n/a |
| Interest Coverage | 143.08 |
Financial Efficiency
Return on equity (ROE) is 23.46% and return on invested capital (ROIC) is 20.32%.
| Return on Equity (ROE) | 23.46% |
| Return on Assets (ROA) | 11.94% |
| Return on Invested Capital (ROIC) | 20.32% |
| Return on Capital Employed (ROCE) | 26.23% |
| Weighted Average Cost of Capital (WACC) | 9.92% |
| Revenue Per Employee | 65.90M |
| Profits Per Employee | 10.60M |
| Employee Count | 2,660 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 4.07 |
Taxes
In the past 12 months, Organo has paid 9.87 billion in taxes.
| Income Tax | 9.87B |
| Effective Tax Rate | 25.92% |
Stock Price Statistics
The stock price has increased by +102.09% in the last 52 weeks. The beta is 1.11, so Organo's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +102.09% |
| 50-Day Moving Average | 14,205.20 |
| 200-Day Moving Average | 11,158.63 |
| Relative Strength Index (RSI) | 44.72 |
| Average Volume (20 Days) | 356,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Organo had revenue of JPY 175.30 billion and earned 28.18 billion in profits. Earnings per share was 613.06.
| Revenue | 175.30B |
| Gross Profit | 63.58B |
| Operating Income | 37.49B |
| Pretax Income | 38.07B |
| Net Income | 28.18B |
| EBITDA | 39.35B |
| EBIT | 37.49B |
| Earnings Per Share (EPS) | 613.06 |
Balance Sheet
The company has 22.07 billion in cash and 31.74 billion in debt, with a net cash position of -9.67 billion or -210.21 per share.
| Cash & Cash Equivalents | 22.07B |
| Total Debt | 31.74B |
| Net Cash | -9.67B |
| Net Cash Per Share | -210.21 |
| Equity (Book Value) | 130.73B |
| Book Value Per Share | 2,843.12 |
| Working Capital | 111.62B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 36.27%, with operating and profit margins of 21.38% and 16.08%.
| Gross Margin | 36.27% |
| Operating Margin | 21.38% |
| Pretax Margin | 21.72% |
| Profit Margin | 16.08% |
| EBITDA Margin | 22.45% |
| EBIT Margin | 21.38% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 190.00, which amounts to a dividend yield of 1.33%.
| Dividend Per Share | 190.00 |
| Dividend Yield | 1.33% |
| Dividend Growth (YoY) | 18.75% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | 1.30% |
| Earnings Yield | 4.22% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 29, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Organo has an Altman Z-Score of 6.3 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.3 |
| Piotroski F-Score | 5 |